Susquehanna International Group
SPHS

Susquehanna International Group’s Sophiris Bio, Inc. SPHS Stock Holding History

Susquehanna International Group’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-73,100
Closed -$204K – 10758
2018
Q3 		$204K Sell
73,100
-19,900
-21% -$56.6K ﹤0.01% 8192
2018
Q2 		$261K Buy
93,000
+31,800
+52% +$94.5K ﹤0.01% 8124
2018
Q1 		$123K Buy
+61,200
New +$133K ﹤0.01% 8623
2017
Q4 		– Sell
-22,800
Closed -$49K – 10475
2017
Q3 		$49K Buy
+22,800
New +$47.2K ﹤0.01% 8546

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $770M AUM 23.14% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's SPHS Position: Q2 2019 in Review

Susquehanna International Group sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 14,379 shares — an estimated $14K sold.

Susquehanna International Group first reported a position in SPHS in Q2 2015 and held it in 10 quarters. The position peaked at $74K in Q2 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

  • Susquehanna International Group reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 14,379 Sophiris Bio, Inc. shares in Q2 2019, an estimated $14K.
  • Susquehanna International Group first reported a position in Sophiris Bio, Inc. in Q2 2015 and held it in 10 quarters.
  • Susquehanna International Group's Sophiris Bio, Inc. position peaked at $74K in Q2 2018.
  • 22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.